Federal Register / Vol. 86, No. 24 / Monday, February 8, 2021 / Notices 8647 

• Lack of consistency for what supplies 

to include in an emergency supply kit: 

While the public can access 

information on what contents are 

likely important to include in 

emergency supply kits, there is a lack 

of information as to whether there is 

a standard set of supplies that is 

consistently needed across disaster 

types 

• Lack of a standard tool for evaluation 

of emergency supply kit use and 

effectiveness 

• Lack of information on how 

emergency supply kit items are used 

during or following disasters: 

Currently we lack detailed 

information on how households use 

emergency supply kit items during or 

following disasters and what, if any, 

are barriers to their use 

• Lack of information on effectiveness 

of emergency supply kits in 

preventing adverse outcomes: To our 

knowledge, there is no information on 

whether the use of emergency supply 

items prevents adverse health 

outcomes. Among individuals with 

health conditions, it remains unclear 

whether preparing an emergency 

supply kit with adequate medications 

and medical supplies prevents the 

worsening of conditions or the need 

for emergency medical services 

• Lack of data to support emergency 

supply kit recommendations: It is 

unclear whether having essential 

supplies improves self-sufficiency 

and lessens the need for outside 

assistance 

This general lack of research on the 

efficacy and use of emergency supply 

kits impedes our ability to make datadriven recommendations regarding 

emergency supply kit promotion. The 

cross-sectional disaster survey and focus 

group(s) on the public’s knowledge, 

preparedness, and use of emergency 

supply kits will identify and inform 

public health officials about the most 

useful items to include in an emergency 

supply kit, ideally across two different 

types of disasters. 

Survey participants will be selected 

via address-based sampling in the 

defined geographic area impacted by the 

disaster and given the choice to 

complete the survey via paper (i.e., 

Teleform) or online via a web-based 

instrument. Survey participants will 

also be recruited using an existing, 

nonprobability web panel and be 

directed to the online, web-based 

instrument to create a larger, more costeffective dataset. Focus group 

participants will be randomly selected 

among survey respondents and/or 

recruited via targeted social media (e.g., 

Facebook, Craigslist) to provide context 

and enhancement to the survey. 

The estimated annualized burden is 

384 hours. The estimated burden is 

based on conducting the survey at one 

site per year, taking 15 minutes per 

respondent via the web or 30 minutes 

via paper survey, and up to two focus 

groups in each site taking approximately 

five minutes for the focus group 

screener and two hours for the focus 

group. There is no cost to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

General public ...................................... Web survey ............................................................... 667 1 15/60 

Paper survey ............................................................. 333 1 30/60 

Focus group screener ............................................... 24 1 5/60 

Focus group .............................................................. 24 1 2 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–02549 Filed 2–5–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30 Day–21–20OS] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘COVID–19 

Pandemic Response, Laboratory Data 

Reporting’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on June 5th, 

2020 to obtain comments from the 

public and affected agencies. CDC 

received two comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 


jbell on DSKJLSW7X2PROD with NOTICES
8648 Federal Register / Vol. 86, No. 24 / Monday, February 8, 2021 / Notices 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

COVID–19 Pandemic Response, 

Laboratory Data Reporting—New— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Efforts are underway to ensure that 

laboratory data—including diagnostic 

viral testing data and serologic testing 

data—are comprehensive and readily 

available from laboratories and other 

facilities providing testing, including 

point-of-care (POC) testing sites for the 

public health response to SARS-CoV–2 

and COVID–19. 

Ensuring a rapid and thorough public 

health response to the COVID–19 

pandemic necessitates comprehensive 

laboratory testing data. These data 

contribute to understanding disease 

incidence and trends: Initiating 

epidemiologic case investigations, 

assisting with contact tracing, assessing 

availability and use of testing resources, 

and identifying supply chain issues for 

reagents and other material. Laboratory 

testing data, in conjunction with case 

reports and other data, also provide vital 

guidance for mitigation and control 

activities. The total estimated 

annualized burden is 65,936 hours. 

There are no costs to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

State epidemiologist or 

informatics staff.

CDC-provided CSV file or HL7 messages ............................. 54 180 1 

CDC-provided CSV file or HL7 messages (retrospective 

data entry).

54 1 4 

IT professional ........................ LIMS interface configuration .................................................. 7,000 1 8 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–02548 Filed 2–5–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30 Day–21–20OM] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Medical 

Monitoring Project Facility Survey to 

the Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on June 2, 2020 to obtain 

comments from the public and affected 

agencies. CDC received one comment 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Medical Monitoring Project Facility 

Survey—New—National Center for HIV/ 

AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention requests a one year approval 

for a new information collection, 

‘‘Medical Monitoring Project (MMP) 

Facility Survey.’’ The primary objective 

of the MMP Facility Survey will be to 

conduct a one-time survey of the 

characteristics of HIV care facilities in 

order to collect information on the 

nation’s existing HIV care infrastructure 

and the capacity of facilities to 

implement the strategies of the U.S. 

Ending the HIV Epidemic federal 

initiative. CDC will also use the findings 

to guide national and local HIV 

prevention and care efforts and identify 

gaps as part of the Division of HIV/AIDS 

Prevention’s Strategic Plan. Specifically, 

information is needed about the 

capacity of care facilities to deliver care 

and prevention services, provide HIV 

prevention messaging, partner with 

public health programs, offer services 

for HIV negative partners of HIV 

positive persons, engage and retain 

patients, offer PrEP, medication-assisted 

therapy (MAT), and substance use 


jbell on DSKJLSW7X2PROD with NOTICES